Literature DB >> 18313542

Screening for colorectal cancer.

Jack S Mandel1.   

Abstract

Although there are several methods available for colon cancer screening, none is optimal. This article reviews methods for screening, including fecal occult blood tests, flexible sigmoidoscopy, colonoscopy, CT colonography, capsule endoscopy, and double contrast barium enema. A simple, inexpensive, noninvasive, and relatively sensitive screening test is needed to identify people at risk for developing advanced adenomas or colorectal cancer who would benefit from colonoscopy. It is hoped that new markers will be identified that perform better. Until then we fortunately have a variety of screening strategies that do work.

Entities:  

Mesh:

Year:  2008        PMID: 18313542     DOI: 10.1016/j.gtc.2007.12.007

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

1.  'Simple and easy:' providers' and latinos' perceptions of the fecal immunochemical test (FIT) for colorectal cancer screening.

Authors:  Claudia X Aguado Loi; Dinorah Martinez Tyson; Enmanuel A Chavarria; Liliana Gutierrez; Lynne Klasko; Stacy Davis; Diana Lopez; Tracy Johns; Cathy D Meade; Clement K Gwede
Journal:  Ethn Health       Date:  2018-01-10       Impact factor: 2.772

2.  SALL4 as a new biomarker for early colorectal cancers.

Authors:  Sima Ardalan Khales; Mohammad Reza Abbaszadegan; Abbas Abdollahi; Reza Raeisossadati; Mohsen Fallah Tousi; Mohammad Mahdi Forghanifard
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

3.  Barrier-focused intervention to increase colonoscopy attendance among nonadherent high-risk populations.

Authors:  Wen Meng; Xi-Wen Bi; Xiao-Yin Bai; Hua-Feng Pan; Shan-Rong Cai; Qi Zhao; Su-Zhan Zhang
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

4.  Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.

Authors:  Guang-Jun Zhang; Tong Zhou; Zuo-Liang Liu; Hong-Peng Tian; Shu-Sen Xia
Journal:  Mol Clin Oncol       Date:  2013-01-07

5.  Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.

Authors:  Rui Wang; Lutao Du; Xiaoyun Yang; Xiumei Jiang; Weili Duan; Suzhen Yan; Yujiao Xie; Yuntao Zhu; Qingliang Wang; Lili Wang; Yongmei Yang; Chuanxin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-03       Impact factor: 4.553

6.  Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor marker?

Authors:  Nikiforos Ballian; Shi-He Liu; Francis-Charles Brunicardi
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

7.  Patients' perceptions of colorectal cancer screening tests and preparatory education in federally qualified health centers.

Authors:  Clement K Gwede; Alexis M Koskan; Gwendolyn P Quinn; Stacy N Davis; Jamila Ealey; Rania Abdulla; Susan T Vadaparampil; Gloria Elliott; Diana Lopez; David Shibata; Richard G Roetzheim; Cathy D Meade
Journal:  J Cancer Educ       Date:  2015-06       Impact factor: 2.037

8.  Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.

Authors:  G Zheng; L Du; X Yang; X Zhang; L Wang; Y Yang; J Li; C Wang
Journal:  Br J Cancer       Date:  2014-09-18       Impact factor: 7.640

9.  Evaluation of circulating microRNAs-211 and 25 as diagnostic biomarkers of colorectal cancer.

Authors:  Eman Radwan; Asmaa S Shaltout; Shima Gafar Mansor; Engy A Shafik; Wael A Abbas; Mahmoud Refaat Shehata; Maha Ali
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

10.  Prognostic Significance of DR-70 Levels in Dysplastic Colorectal Polyps.

Authors:  Atakan Yesil; Gul Babacan Abanonu; Yasar Colak; Nurcan Paker; Can Gonen
Journal:  Gastroenterol Res Pract       Date:  2013-11-21       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.